Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting
- PMID: 25298237
- DOI: 10.1093/eurheartj/ehu383
Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting
Abstract
Aim: Routine control angiography is a valuable tool with high-sensitivity in detecting restenosis after coronary stenting. However, the prognostic role of restenosis is still controversial. We investigated the impact of restenosis on 4-year mortality in patients undergoing routine control angiography after coronary stenting.
Methods and results: All the patients undergoing successful implantation of coronary stents for de novo lesions from 1998 to 2009 and routine control angiography after 6-8 months at two centres in Munich, Germany were studied. Restenosis was defined as diameter stenosis ≥50% in the in-segment area at follow-up angiography. The primary outcome was 4-year mortality. The study included 10 004 patients with 15 004 treated lesions. Restenosis was detected in 2643 (26.4%) patients. Overall, there were 702 deaths during the follow-up. Of these, 218 deaths occurred among patients with restenosis and 484 deaths occurred among patients without restenosis [unadjusted hazard ratio: HR: 1.19; (95% confidence interval CI: 1.02-1.40); P = 0.03]. The Cox proportional hazards model adjusting for other variables identified restenosis as an independent correlate of 4-year mortality [HR: 1.23; (95% CI: 1.03-1.46); P = 0.02]. Other independent correlates of 4-year mortality were age [for each 10-year increase, HR: 2.34; (95% CI: 2.12-2.60); P < 0.001], diabetes mellitus [HR: 1.68; (95% CI: 1.41-1.99); P < 0.001], current smoking habit [HR: 1.39; (95% CI: 1.09-1.76); P = 0.01], and left ventricular ejection fraction [for each 5% decrease, HR: 1.39; (95% CI: 1.31-1.48); P < 0.001].
Conclusions: In this large cohort of patients, the presence of restenosis at follow-up angiography after coronary stenting was predictive of 4-year mortality. Whether routine control angiography after coronary stenting is beneficial and influences outcomes should be evaluated by properly designed randomized trials.
Keywords: Angiography; Coronary artery disease; Mortality; Restenosis.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.
Comment in
-
Routine angiographic surveillance for risk stratification in PCI-treated patients: fact or fiction?Eur Heart J. 2015 Jan 7;36(2):71-4. doi: 10.1093/eurheartj/ehu398. Epub 2014 Oct 21. Eur Heart J. 2015. PMID: 25336220 No abstract available.
-
Interventional cardiology: Restenosis predictive of 4-year mortality after stenting.Nat Rev Cardiol. 2014 Dec;11(12):688. doi: 10.1038/nrcardio.2014.172. Epub 2014 Oct 28. Nat Rev Cardiol. 2014. PMID: 25348692 No abstract available.
Similar articles
-
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.Heart. 2014 Jan;100(2):153-9. doi: 10.1136/heartjnl-2013-304933. Epub 2013 Nov 22. Heart. 2014. PMID: 24270744
-
Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.JACC Cardiovasc Interv. 2014 Jul;7(7):751-8. doi: 10.1016/j.jcin.2014.02.012. JACC Cardiovasc Interv. 2014. PMID: 25060017 Clinical Trial.
-
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E23-8. doi: 10.1002/ccd.24375. Epub 2012 May 4. Catheter Cardiovasc Interv. 2013. PMID: 22431239 Clinical Trial.
-
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11. JACC Cardiovasc Interv. 2014. PMID: 24332416 Clinical Trial.
-
Antibody-coated stents for the treatment of coronary artery stenosis in patients at high risk of restenosis: Executive summary of rapid report N12-01, Version 1.1.2012 Sep 7. Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005–. 2012 Sep 7. Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005–. PMID: 24783304 Free Books & Documents. Review.
Cited by
-
Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database.Heart Vessels. 2019 Jan;34(1):33-43. doi: 10.1007/s00380-018-1224-3. Epub 2018 Jul 14. Heart Vessels. 2019. PMID: 30008123
-
Novel treatments for in-stent restenosis: sirolimus-eluting balloons enter the arena.J Thorac Dis. 2018 Feb;10(2):628-630. doi: 10.21037/jtd.2018.01.04. J Thorac Dis. 2018. PMID: 29607125 Free PMC article. No abstract available.
-
Comparative efficacy of the five most common traditional Chinese medicine monomers in reducing intimal hyperproliferation in arterial balloon injury models: A network meta-analysis.Heliyon. 2024 Aug 19;10(17):e36327. doi: 10.1016/j.heliyon.2024.e36327. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263082 Free PMC article.
-
Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging.J Am Heart Assoc. 2021 Oct 19;10(20):e020834. doi: 10.1161/JAHA.121.020834. Epub 2021 Oct 11. J Am Heart Assoc. 2021. PMID: 34632804 Free PMC article.
-
Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis.J Soc Cardiovasc Angiogr Interv. 2024 Feb 20;3(3Part A):101262. doi: 10.1016/j.jscai.2023.101262. eCollection 2024 Mar. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39131776 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical